tirzepatide sales 2024 New weight-loss drugs surge in popularity amid obesity surge in US, worldwide GLP-1 Agonists Weight Loss Drugs

Obesity 32 , 494505 (2024)

GLP-1 medications get most of the attention, but several related expenses can also qualify

A.Bin JardanY

Is tirzepatide more effective than semaglutide for everyone

Key factors include: the drug shortages have been resolved (tirzepatide in October 2024, semaglutide in February 2025), FDA-approved versions are commercially available, and the agency has received over 775 adverse event reports linked to compounded versions, many involving dosing errors from multi-dose vials

Additionally, patients should seek medical attention for fever accompanied by signs of severe dehydration, including decreased urination, dark urine, dizziness, or confusion